HomeHEMO • LON
add
Hemogenyx Pharmaceuticals PLC
Previous close
GBX 1.57
Day range
GBX 1.53 - GBX 1.62
Year range
GBX 1.10 - GBX 7.13
Market cap
21.00M GBP
Avg Volume
7.87M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
(GBP) | Jun 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 2.11M | 268.79% |
Net income | -2.16M | -283.19% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.05M | -269.61% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(GBP) | Jun 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.08M | -46.81% |
Total assets | 7.22M | -7.88% |
Total liabilities | 3.59M | 273.15% |
Total equity | 3.63M | — |
Shares outstanding | 1.14B | — |
Price to book | ∞ | — |
Return on assets | -72.96% | — |
Return on capital | -76.44% | — |
Cash Flow
Net change in cash
(GBP) | Jun 2023info | Y/Y change |
---|---|---|
Net income | -2.16M | -283.19% |
Cash from operations | -1.69M | -261.15% |
Cash from investing | 20.77K | 10,231.34% |
Cash from financing | 1.80M | 66,273.31% |
Net change in cash | 276.05K | 153.01% |
Free cash flow | -1.19M | -258.30% |
About
Founded
2012
Website
Employees
17